No Picture
News

Gynesonics Announces Publication of CHOICES: A Comparative Study of the Sonata Treatment VERSUS Myomectomy

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the peer reviewed publication of CHOICES, a comparative, case-matche… […]

No Picture
News

Gilead-partnered Goldfinch Bio lands $100M as it pivots to clinical stage biotech

A year after landing $109 million in cash for an early-stage discovery deal with Gilead, Goldfinch Bio has scored a similar bounty from investors, raising $100 million in the biotech’s first financing round since its 2016 launch.
The new round, led by … […]